Both c-Myc and IRF4 are known oncogenes in MM, owing to their ability to support growth and survival.7, 9 Although the molecular mechanisms of c-Myc and IRF4 expression is complex, our findings here suggest that Ikaros and Aiolos are involved in the regulation of their transcriptional activity. This evidence concerns the gene MYC and Miyoshi myopathy.